Location
: Barcelona - Spain (3 days working from the office and 2 days working from home)
At
Alexion, AstraZeneca Rare Disease
, this role offers the opportunity to shape access for transformative medicines in areas of high unmet need and make a meaningful impact for patients living with
rare neurological diseases
. You will operate in a highly visible, strategic position with broad cross-functional exposure, leading portfolio-level market access, pricing, and reimbursement strategy across key markets, with a particular focus on the
NMOSD
indication. This is an opportunity for an experienced market access leader to influence critical launch and lifecycle decisions, navigate complex payer environments, and play a central role in advancing our ambition within
Neurology
.
Whatyou'llwilldo:
Join a highly valued, strategic team that is fundamental to realizing the potential of our life-changing medicines. Through our work, AstraZenecais able toensure that appropriate access is provided to our transformative therapies.
Alexion, AstraZeneca Rare Disease'sGlobal Value Access and Pricing (
GVAP
) team is seeking a qualified
Director
to join a dynamic and growing team, with responsibility for
Neurology
indications, including near-term new product launches and label expansions.
As a key member of the
GVAP
team, you will help shape and execute global value, access, and pricing strategies across the
Neurology portfolio
in selected key EU markets
, withparticular strategicfocus on the
NMOSD indication
and its lifecycle management
This is a strategic role that leverages your understanding and application of global healthcare and health technology assessment (
HTA
) systems, competitive insights,



and clinical knowledge to shape market access, pricing, and reimbursement success for critical product launches and indications.
The ideal candidate for this role will have deep expertise in global payer,
HTA
, and reimbursement ecosystems, with a strong track record of driving market access, pricing, and reimbursement success within
rare diseases and Neurology
.
You will be responsible for:
Value
Lead and drive cross-functional development of a clear, differentiated value proposition for
NMOSD
, while influencing without authority and navigating complex organizational systems.
Collaborate with cross-functional teams to ensure that evidence generation plans and real-world evidence (
RWE
) are incorporated effectively to deliver a comprehensive value proposition, reduce uncertainty for payers, and optimize patient access. This includes securing timely country input on endpoints and evidence generation plans in priority target countries.
Provide support to the
GMMA Commercial
team to advance
NMOSD lifecycle management (LCM)
through governance milestones focused on market access potential, evidence, and
target product profile (TPP)
requirements.
Access
Leaddevelopmentofglobal market access and pricing strategies-activitiesandsupport implementationin close partnership with country access representativesofassigned countries




Lead the assessment of pricing and reimbursement (
P&R;
) risks and opportunities, and the implementation of corresponding mitigation actions specific to
Neurology
.
Create and roll out strategic value, access, and pricing communication tools and materials for
NMOSD
to support local
P&R;
submissions and negotiations, such as pricing frameworks, negotiation strategies, and toolkits, in alignment with the enterprise-wide launch framework.
Lead the update of the integral reimbursement dossier for
NMOSD
and the overall cross-functional market access readiness plans for
Neurology
, in close collaboration with key countries and support functions (
HEOR, Medical, and Commercial
).
Represent the
GVAP
perspective and strategy across various cross-functional teams, including the
Global Value Sub-Team
and
Global Launch Team
, and provide updates and guidance to local teams as needed.
Own the monthlyNeurologypayer working group to share the latest evidence and drive best practice sharing across countries.
Understand and incorporate thepatientperspective on thedisease, andrecommend strategies that support thepatientvoice in key payer negotiations.
Pricing
Support the development ofthe
Neurology
pricing strategy.
Conduct payer and value assessments to identify key market-specific P&R; drivers and barriers, develop differentiated value propositions, and inform evidence generation plans, regulatory strategy, and development decisions.
For the top EU Neurology markets, lead and co-create market-level P&R; strategies and support P&R; submissions and negotiations to drive positive outcomes.
Review P&R; ca

📌 Global Pricing (Barcelona)
🏢 Alexion
📍 Barcelona